Novartis agrees on potential $3bn deal to buy Synnovations’s breast cancer treatment
The oral drug is currently being evaluated for breast cancer and other advanced solid tumours in a phase 1/2 study
Read More
Section: Sales
GSK to acquire 35Pharma for $950m including a potential drug for pulmonary hypertension
PH has a five‑year survival rate of only around 50% and affects up to 82 million people worldwide
Read More
Lilly announces acquisition of Ventyx Biosciences for around $1.2bn
Multiple Ventyx drugs are currently in phase 2 development for inflammatory disease
Read More
UK and US agree on landmark pharma pricing tariff deal
US tariffs on UK-produced pharmaceuticals will remain at zero for three years
Read More
Pfizer and Metsera agree on merger after bidding war between Pfizer and Novo Nordisk
The Pfizer bid was chosen by Metsera after a concern was raised about US antitrust laws regarding the Novo Nordisk offer
Read More